API
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 2 sources · 22 days · First seen · Last updated

Medical diagnostic and testing market trends

Overview

The medical testing sector is seeing growth across different specialized segments. The global Point-of-Care Testing (POCT) market is projected to increase from approximately US$22.69 billion in 2025 to US$36.83 billion by 2032, driven by a shift toward integrated clinical decision-making platforms and rising demand for rapid testing in chronic disease management and infectious diseases.

Simultaneously, the bioanalytical testing services market is expected to grow from an estimated $5.66 billion in 2025 to $16.47 billion by 2036. This growth is fueled by the increasing complexity of modern therapeutics, such as precision medicines and antibody-drug conjugates, which require specialized analytical methods for drug discovery and clinical trials.

Entities

ICH · Abbott · Thermo Fisher Scientific · Siemens Healthineers · Danaher

Timeline

  1. [BUSINESS] 2 sources
    Bioanalytical testing services market projected to reach $16.47 billion by 2036

    The bioanalytical testing services market is forecasted to grow at a 10.2% CAGR, reaching $16.47 billion by 2036, driven by complex drug development and outsourcing trends.

  2. [BUSINESS] 2 sources
    Global POCT market projected to reach US$36.83 billion by 2032

    The global POCT market is expected to reach US$36.83 billion by 2032, growing at a 7.27% CAGR as testing shifts toward integrated clinical decision platforms.

Sources

dreamnews.jp · tmtpost.com